| Financial Year |
March 31 2021 |
| Monetary Funds |
16,376,959.54 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
1,000,000.00 |
| Accounts Receivable |
123,106,350.45 |
| Advances to Suppliers |
58,234,502.17 |
| Other Receivables |
50,573,571.05 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
123,413,521.53 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
5,212,477.43 |
| Total Current Assets |
377,917,382.17 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
248,562.06 |
| Investment Properties |
-- |
| Fixed Assetes |
177,017,498.13 |
| Under-construction Projects |
24,332,174.98 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
140,516,129.09 |
| R&D expenses |
-- |
| Goodwill |
70,893,888.36 |
| Long-Term Deferred and Prepaid Expenses |
14,248,597.10 |
| Deferred Income Tax Assets |
48,567,015.67 |
| Other Non-Current Assets |
27,169.97 |
| Sub-Total of Non-Current Assets |
652,708,116.06 |
| Total Assets |
1,030,625,498.23 |
| Short-Term Loans |
317,914,251.93 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
37,075,319.14 |
| Accounts Received In Advance |
19,354,472.94 |
| Employee Compensation Payable |
3,269,916.74 |
| Taxes Payable |
43,787,430.24 |
| Interest Payable |
56,801,696.98 |
| Dividend Payable |
3,551,509.33 |
| Other payables |
794,366,892.61 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
515,655,383.01 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
1,731,423,666.61 |
| Long-term Loans |
4,700,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
125,661,835.69 |
| Deferred Income Tax Liabilities |
22,780,871.67 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
174,258,263.22 |
| Total Liabilities |
1,905,681,929.83 |
| Paid-In Capital(Or Share Stock) |
525,429,878.00 |
| Capital Surplus |
-486,362,570.38 |
| Surplus Reserve |
-1,092,444,485.12 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-- |
| Minority Stockholder's Interest |
178,320,745.90 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
-1,053,377,177.50 |
| Owner's Equity（Stockholder's Equity） |
-875,056,431.60 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,030,625,498.23 |
